Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2026-01-02 @ 6:03 AM
Study NCT ID:
NCT00803868
Status:
TERMINATED
Last Update Posted:
2012-07-24
First Post:
2008-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
Sponsor:
University of South Florida
Organization:
Study Overview
Official Title:
Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
Status:
TERMINATED
Status Verified Date:
2012-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The DSMB recommended that the study be stopped as a result of concerns regarding safety and intolerability and insufficient evidence of efficacy.
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if varenicline is effective in treating symptoms of Friedreich's ataxia.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: